Grant Verstandig
QuietNamed in filings at Red Cell PartnersOn the current fund
- Board seats filed
- 4
Named in filings at Red Cell PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Andesite AI | Not yet classified | November 2023 | None on file |
| Zephyr AI | Digital health | January 2022 | None on file |
| Epirus | Aerospace & defense | October 2019 | 8VC |
| Audax Health Solutions | Digital health | June 2013 | QED, QED Investors |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Grant Verstandig on the board, based on 3 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.